av/cymabay-therapeutics--big.svg

COM:CYMABAY

CymaBay Therapeutics Inc

  • Stock

USD

Last Close

32.47

21/03 20:00

Market Cap

3.73B

Beta: -

Volume Today

8.35M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-10.07M
-
-31.92M
216.86%
-15.53M
51.35%
-26.67M
71.75%
-27.56M
3.32%
-72.55M
163.27%
-102.81M
41.71%
-50.99M
50.41%
-90.00M
76.52%
-106.00M
17.78%
-105.37M
0.60%
depreciation and amortization
55K
-
18K
67.27%
22K
22.22%
29K
31.82%
35K
20.69%
105K
200%
572K
444.76%
632K
10.49%
688K
8.86%
710K
3.20%
681K
4.08%
deferred income tax
-90K
-
7.69M
8,645.56%
-10.61M
237.95%
50K
100.47%
5.57M
11,048%
1.75M
68.60%
-3.15M
279.83%
637K
-
-2.73M
-
stock based compensation
892K
-
1.29M
44.84%
2.49M
92.49%
2.47M
0.56%
4.92M
98.95%
7.01M
42.54%
10.47M
49.27%
7.32M
30.03%
10.00M
36.48%
9.52M
4.79%
15.23M
60.03%
change in working capital
701K
-
1.60M
128.82%
78K
95.14%
290K
271.79%
-3.04M
1,148.62%
8.86M
391.32%
-3.91M
144.09%
-1.59M
59.27%
6.35M
499.18%
-2.34M
136.83%
5.63M
340.79%
accounts receivables
-2K
-
-101K
4,950%
211K
308.91%
-5M
-
inventory
699K
-
304K
56.51%
938K
208.55%
1.43M
-
accounts payables
40K
-
1.39M
3,370.00%
-1.08M
177.59%
-109K
89.88%
412K
477.98%
662K
60.68%
530K
19.94%
-2.27M
528.68%
2.31M
201.63%
-1.44M
162.54%
2.73M
289.20%
other working capital
-36K
-
13K
136.11%
6K
53.85%
399K
6,550%
120K
69.92%
8.20M
6,730.83%
-4.44M
154.12%
681K
115.35%
4.04M
493.54%
-895K
122.14%
2.90M
424.02%
other non cash items
57K
-
198K
247.37%
228K
15.15%
476K
108.77%
437K
8.19%
-115K
126.32%
910K
891.30%
-104K
111.43%
2.90M
2,883.65%
14.03M
384.73%
14.03M
0.04%
net cash provided by operating activities
-8.46M
-
-21.11M
149.63%
-23.32M
10.47%
-23.35M
0.12%
-19.63M
15.93%
-54.94M
179.83%
-97.91M
78.23%
-44.73M
54.32%
-69.43M
55.24%
-84.08M
21.10%
-72.53M
13.74%
investments in property plant and equipment
-103K
-
-42K
-
-27K
35.71%
-529K
1,859.26%
-315K
40.45%
-21K
93.33%
-87K
314.29%
-148K
70.11%
-445K
200.68%
acquisitions net
-199K
-
-1.95M
877.39%
-2.24M
15.01%
-104K
95.35%
637K
712.50%
-874K
237.21%
-7.86M
799.77%
purchases of investments
-6.93M
-
-27.33M
294.26%
-42.79M
56.54%
-22.91M
46.47%
-98.39M
329.52%
-276.38M
180.92%
-290.89M
5.25%
-176.30M
39.39%
-78.08M
55.71%
-174.98M
124.09%
-305.67M
74.69%
sales maturities of investments
44K
-
10.50M
23,761.36%
31.70M
201.98%
50.08M
57.94%
30.88M
38.33%
222.80M
621.41%
256.86M
15.29%
224.28M
12.69%
126.76M
43.48%
129.14M
1.88%
219.55M
70.01%
other investing activites
658K
-
199K
-
1.95M
877.39%
2.24M
15.01%
104K
95.35%
-637K
712.50%
874K
237.21%
7.86M
799.77%
net cash used for investing activites
-6.23M
-
-16.94M
171.83%
-11.08M
34.57%
27.13M
344.77%
-67.53M
348.92%
-54.11M
19.87%
-34.35M
36.52%
47.96M
239.63%
48.59M
1.32%
-45.98M
194.64%
-86.57M
88.25%
debt repayment
-244K
-
-4.76M
1,849.18%
-986K
79.27%
-3.14M
218.15%
-6.53M
108.07%
-47.74M
-
-25M
47.63%
common stock issued
26.51M
-
25.43M
4.09%
25.38M
0.22%
100.44M
-
135.52M
34.93%
107.75M
20.49%
92K
99.91%
70.50M
76,529.35%
-459K
100.65%
345.77M
75,431.59%
common stock repurchased
-3K
-
-459K
-
dividends paid
-25M
-
other financing activites
4.85M
-
51K
98.95%
9.91M
19,327.45%
2.42M
-
6.00M
147.73%
386K
93.56%
92K
76.17%
95.69M
103,914.13%
75.47M
21.14%
net cash used provided by financing activities
31.36M
-
25.24M
19.54%
30.53M
20.96%
-986K
103.23%
99.72M
10,213.49%
134.99M
35.37%
108.13M
19.90%
92K
99.91%
118.45M
128,655.43%
24.55M
79.27%
345.77M
1,308.44%
effect of forex changes on cash
-428K
-
net change in cash
16.68M
-
-12.81M
176.85%
-3.88M
69.72%
2.79M
171.88%
12.56M
350.30%
25.94M
106.55%
-24.13M
193.00%
3.32M
113.78%
97.61M
2,836.61%
-105.52M
208.10%
186.24M
276.51%
cash at beginning of period
7.73M
-
24.40M
215.83%
11.59M
52.52%
7.71M
33.49%
10.49M
36.19%
23.05M
119.67%
48.99M
112.52%
24.87M
49.24%
28.19M
13.37%
125.81M
346.23%
20.29M
83.87%
cash at end of period
24.40M
-
11.59M
52.52%
7.71M
33.49%
10.49M
36.19%
23.05M
119.67%
48.99M
112.52%
24.87M
49.24%
28.19M
13.37%
125.81M
346.23%
20.29M
83.87%
206.53M
917.87%
operating cash flow
-8.46M
-
-21.11M
149.63%
-23.32M
10.47%
-23.35M
0.12%
-19.63M
15.93%
-54.94M
179.83%
-97.91M
78.23%
-44.73M
54.32%
-69.43M
55.24%
-84.08M
21.10%
-72.53M
13.74%
capital expenditure
-103K
-
-42K
-
-27K
35.71%
-529K
1,859.26%
-315K
40.45%
-21K
93.33%
-87K
314.29%
-148K
70.11%
-445K
200.68%
free cash flow
-8.46M
-
-21.22M
150.85%
-23.32M
9.93%
-23.39M
0.30%
-19.66M
15.97%
-55.47M
182.14%
-98.23M
77.10%
-44.75M
54.45%
-69.52M
55.36%
-84.23M
21.16%
-72.98M
13.36%

All numbers in USD (except ratios and percentages)